These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 15611969

  • 1. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H, Lindner V, de Fromont M, Molinié V, Letourneux H, Meyer N, Martin M, Jacqmin D.
    Cancer; 2005 Feb 01; 103(3):625-9. PubMed ID: 15611969
    [Abstract] [Full Text] [Related]

  • 2. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W.
    Cancer; 2005 Jan 01; 103(1):68-75. PubMed ID: 15573369
    [Abstract] [Full Text] [Related]

  • 3. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
    Bektas S, Bahadir B, Kandemir NO, Barut F, Gul AE, Ozdamar SO.
    Kaohsiung J Med Sci; 2009 Nov 01; 25(11):596-600. PubMed ID: 19858038
    [Abstract] [Full Text] [Related]

  • 4. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.
    Cancer; 2008 Aug 01; 113(3):477-83. PubMed ID: 18484589
    [Abstract] [Full Text] [Related]

  • 5. Prognostic ability of simplified nuclear grading of renal cell carcinoma.
    Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra V, Cindolo L, de la Taille A, Tostain J, Zigeuner R, Mejean A, Patard JJ.
    Cancer; 2007 Mar 01; 109(5):868-74. PubMed ID: 17262800
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 01; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 7. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH.
    Am J Surg Pathol; 2010 Sep 01; 34(9):1233-40. PubMed ID: 20679882
    [Abstract] [Full Text] [Related]

  • 8. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR.
    Am J Surg Pathol; 2011 Aug 01; 35(8):1134-9. PubMed ID: 21716085
    [Abstract] [Full Text] [Related]

  • 9. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.
    Eur Urol; 2005 Oct 01; 48(4):593-600. PubMed ID: 15964127
    [Abstract] [Full Text] [Related]

  • 10. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK.
    Eur J Surg Oncol; 2016 Mar 01; 42(3):419-25. PubMed ID: 26520403
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.
    Actas Urol Esp; 2010 Jan 01; 34(1):71-7. PubMed ID: 20223135
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
    J Urol; 2011 Dec 01; 186(6):2168-74. PubMed ID: 22014797
    [Abstract] [Full Text] [Related]

  • 17. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.
    Am J Surg Pathol; 2007 Jun 01; 31(6):957-60. PubMed ID: 17527087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 01; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
    Sichani MM, Yazdi FS, Moghaddam NA, Chehrei A, Kabiri M, Naeimi A, Taheri D.
    Saudi J Kidney Dis Transpl; 2010 Jan 01; 21(1):69-74. PubMed ID: 20061696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.